1. Home
  2. CADL

CADL

Candel Therapeutics Inc.

Logo Candel Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 12:29pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Founded: 1999 Country:
United States
United States
Employees: N/A City: NEEDHAM
Market Cap: 170.8M IPO Year: 2021
Target Price: $7.00 AVG Volume (30 days): 5.3M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.31 EPS Growth: N/A
52 Week Low/High: $0.66 - $11.40 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: